FDA Permits Marketing of Artificial Intelligence-Based IDx-DR for Detection of Diabetic Retinopathy
FDA Permits Marketing of Artificial Intelligence-Based IDx-DR for Detection of Diabetic Retinopathy By: FDA News The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic [..]